Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -70,875 | -40,595 | -19,881 | -70,279 | -51,501 |
| Depreciation Amortization | 4,964 | 3,391 | 1,736 | 7,712 | 5,716 |
| Accounts receivable | -1,608 | -1,144 | -237 | -1,785 | -1,717 |
| Accounts payable and accrued liabilities | 1,032 | -700 | 590 | -1,460 | -1,857 |
| Other Working Capital | -17,916 | -17,801 | -8,915 | -24,627 | -24,570 |
| Other Operating Activity | 8,720 | 7,032 | 2,456 | 13,919 | 11,456 |
| Operating Cash Flow | $-75,683 | $-49,817 | $-24,251 | $-76,520 | $-62,473 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -365 | -299 | -71 | -1,002 | -772 |
| Purchase Of Investment | -125,995 | -12,931 | -12,931 | -46,420 | -34,407 |
| Sale Of Investment | 42,804 | 40,318 | 22,439 | 16,904 | 8 |
| Investing Cash Flow | $-83,556 | $27,088 | $9,437 | $-30,518 | $-35,171 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 25,000 | N/A |
| Common Stock Issued | 281,439 | 19,139 | 4,545 | 61,656 | 61,121 |
| Other Financing Activity | 20,000 | 0 | 0 | -425 | 0 |
| Financing Cash Flow | $301,439 | $19,139 | $4,545 | $86,231 | $61,121 |
| Beginning Cash Position | 65,126 | 65,126 | 65,126 | 85,933 | 85,933 |
| End Cash Position | 207,326 | 61,536 | 54,857 | 65,126 | 49,410 |
| Net Cash Flow | $142,200 | $-3,590 | $-10,269 | $-20,807 | $-36,523 |
| Free Cash Flow | |||||
| Operating Cash Flow | -75,683 | -49,817 | -24,251 | -76,520 | -62,473 |
| Capital Expenditure | -365 | -299 | -71 | -1,002 | -772 |
| Free Cash Flow | -76,048 | -50,116 | -24,322 | -77,522 | -63,245 |